Recent Updates
Recently added Catalysts
NAGE Positive Sentiment

Niagen Bioscience to Present at the 17th Annual Midwest IDEAS Investor Conference

Key Takeaway: Niagen Bioscience, Inc. will present at the 17th Annual Midwest IDEAS Investor Conference on August 27, 2026. The event will take place at The InterContinental Chicago, providing a platform for the company to showcase its investment potential. Niagen is known for its expertise in NAD+ and healthy aging.

Market Sentiment Analysis

POSITIVE FACTORS

  • Niagen Bioscience is recognized as a global authority on NAD+.
  • The presentation at a notable investor conference highlights the company's visibility.
  • Focus on healthy aging aligns with growing market interest.

Full Press Release Details

LOS ANGELES--(BUSINESS WIRE)---- $NAGE #Biotech--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that senior management will present at the Midwest IDEAS Investor Conference on Thursday, August 27, 2026, at The InterContinental Chicago in Chicago, IL. IDEAS Conferences offer independent regional venues for top-tier companies to present their investment merits to instrumental audiences of investme

Frequently Asked Questions

When will Niagen Bioscience present at the conference?

Niagen Bioscience will present on August 27, 2026.

Where is the Midwest IDEAS Investor Conference held?

The conference will take place at The InterContinental Chicago in Chicago, IL.

What is the focus of Niagen Bioscience?

Niagen Bioscience focuses on NAD+ and the science of healthy aging.

What is the significance of the IDEAS Conference?

The IDEAS Conference provides a platform for companies to present to potential investors.

Last updated: Aug 12, 2026